Knick at ISPE Europe Annual Conference

This European Annual Conference draws pharmaceutical and biopharmaceutical professionals at all levels of the industry – from students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices, equipment and services, and global regulatory agencies. We welcome you to participate at the 2024 ISPE Europe Annual Conference to learn and share progress, success stories, best practices and lessons learned.

Knick Elektronische Messgeräte GmbH, a Bio-PAT member, will exhibit at the ISPE Europe Annual Conference in Lisbon at booth 513 (profile).
Explore 𝗔𝗰𝗰𝘂𝗿𝗮𝘁𝗲 𝗺𝗲𝗮𝘀𝘂𝗿𝗲𝗺𝗲𝗻𝘁𝘀 𝗮𝘁 𝗮𝗹𝗹 𝘁𝗶𝗺𝗲𝘀 𝘁𝗵𝗮𝗻𝗸𝘀 𝘁𝗼 𝗮𝘂𝘁𝗼𝗺𝗮𝘁𝗶𝗰 𝗰𝗹𝗲𝗮𝗻𝗶𝗻𝗴, 𝗰𝗮𝗹𝗶𝗯𝗿𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗰𝗼𝗻𝘀𝗲𝗿𝘃𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗽𝗛 𝘀𝗲𝗻𝘀𝗼𝗿𝘀 𝘄𝗶𝘁𝗵 𝗞𝗻𝗶𝗰𝗸’𝘀 𝘂𝗻𝗶𝗾𝘂𝗲 𝗰𝗖𝗮𝗿𝗲 𝘀𝘆𝘀𝘁𝗲𝗺!
Automation throughout the upstream, downstream, and auxiliary processes helps to reduce the risks of human errors, improves operational efficiency, and thus increases the safety and quality of the final product which benefits every patient. Knick offers complete measurements loops from sensors to fully automated sensor maintenance systems.

Key Conference Takeaways

Keynotes

• Progress and commercialization of new therapy concepts; example of autologous cell therapies
• EMA’s and FDA’s view on the industry’s preparedness, performance, and challenges for integrating innovation – QRM is in the center! 
• Business roadmap
  • How top manufacturing companies organize the digital transformation: chances, opportunities, benefits, risks and obstacles
  • When reality meets theory in Pharma 4.0 environment.
• Metaverse, a parallel universe of data: how and when can it help the pharmaceutical industry?

Regulatory Panels

• Regulatory Panel 1 with FDA, EMA, WHO and INFARMED
  • This panel will focus on harmonization to break down barriers to robust supply chains. What can industry and regulators deliver in a collaborative approach.
• Regulatory Panel 2 with EMA and Danish Medicines Agency on regulatory preparedness for Digital Transformation.
  • A dialogue between regulators and senior industry leaders.
  • Where is the pharmaceutical industry today on the digital transformational journey from an industry perspective?
  • What about the master data management framework and governance structure? 
  • QRM-based approach in the light of updated ICH Q9:  e.g. formality, subjectivity, risk-based decision making, product availability?

Case Studies

• Digital Transformation: Use Cases, Key Benefits, and Lessons Learned
• Learnings from GXP Inspections to Prepare for the Future
• Regulatory Restrictions and Drug Availability
• Good Engineering Practice and Efficient Investment Management
• GAMP® 5, FDA CSA, cloud computing SAAS, eBatch records with Pharma 4.0

Overview
Exhibitor list
Program
Speakers
Registration

iCal exportieren